Geoffrey von Maltzahn
Founder presso Resonance Therapeutics
Profilo
Founder of 8 different companies, which include: Seres Therapeutics, Inc., Axcella Health, Inc. and Resonance Therapeutics, Geoffrey von Maltzahn and currently holds the position of Chief Executive Officer of Quotient Therapeutics Ltd.
(which he founded in 2022), Chief Innovation Officer & Director at Indigo Ag, Inc. (which he founded in 2013) and General Partner of Flagship Pioneering.
He is also on the board of Tessera Therapeutics, Inc. and Generate Biomedicines, Inc. (former Co-Chief Executive Officer).
In his past career he held the position of Director at Kaleido Biosciences, Inc. (he founded the company in 2015), Chief Technology Officer of Seres Therapeutics, Inc. (he founded the company in 2010), Vice President-Discovery at Axcella Health, Inc. (he founded the company in 2008) and Vice President-Corporate Development of Essentient, Inc. (a subsidiary of Axcella Health, Inc.) and President, Chief Executive Officer & Director at Cobalt Biomedicine, Inc.
He received an undergraduate degree and a doctorate from Massachusetts Institute of Technology and a graduate degree from the University of California San Diego.
Posizioni attive di Geoffrey von Maltzahn
Società | Posizione | Inizio |
---|---|---|
Resonance Therapeutics
Resonance Therapeutics Medical/Nursing ServicesHealth Services Resonance Therapeutics develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics. The company is headquartered in Boston, MA. | Founder | 17/09/2009 |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Founder | 01/01/2013 |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01/01/2009 |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Founder | 01/01/2018 |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Director/Board Member | - |
Precedenti posizioni note di Geoffrey von Maltzahn
Società | Posizione | Fine |
---|---|---|
KALEIDO BIOSCIENCES, INC. | Founder | 15/03/2022 |
SANA BIOTECHNOLOGY, INC. | Director/Board Member | 01/09/2021 |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Chief Executive Officer | 01/02/2019 |
Essentient, Inc.
Essentient, Inc. Miscellaneous Commercial ServicesCommercial Services Essentient, Inc. develops transforming global nutrition. The company involves in research and development in biotechnology. The company was founded in 2008 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 17/02/2014 |
░░░░ ░░░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Geoffrey von Maltzahn
Massachusetts Institute of Technology | Doctorate Degree |
University of California San Diego | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
SERES THERAPEUTICS, INC. | Health Technology |
AXCA HEALPAR | Health Technology |
KALEIDO BIOSCIENCES, INC. | Health Technology |
SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
SANA BIOTECHNOLOGY, INC. | Health Technology |
Aziende private | 7 |
---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Resonance Therapeutics
Resonance Therapeutics Medical/Nursing ServicesHealth Services Resonance Therapeutics develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics. The company is headquartered in Boston, MA. | Health Services |
Essentient, Inc.
Essentient, Inc. Miscellaneous Commercial ServicesCommercial Services Essentient, Inc. develops transforming global nutrition. The company involves in research and development in biotechnology. The company was founded in 2008 and is headquartered in Cambridge, MA. | Commercial Services |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Health Technology |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Health Technology |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Health Technology |